{
    "eu_aut_status": "ACTIVE",
    "eu_brand_name_current": "EU/3/22/2687",
    "status_type": "a",
    "eu_od_number": "EU/3/22/2687",
    "active_substance": "Clarithromycin, clofazimine, rifabutin",
    "eu_od_con": "Treatment of nontuberculous mycobacterial lung disease",
    "eu_od_sponsor": "Regintel Limited",
    "orphan_status": "o",
    "eu_od_date": "2022-08-10",
    "eu_aut_date": "2022-08-10",
    "eu_aut_type_initial": "standard",
    "eu_aut_type_current": "standard",
    "ema_od_number": "EMA/OD/0000093202",
    "ema_number_id": "93202",
    "eu_referral": "False",
    "eu_suspension": "False",
    "ema_number_certainty": "1.0",
    "authorisation_row": "0",
    "scrape_date_web": "22/12/2022",
    "filedates": {
        "EU-3-22-2687_o_dec_0.pdf": {
            "pdf_link": "https://ec.europa.eu/health/documents/community-register/2022/20220810156716/dec_156716_en.pdf",
            "pdf_date": "2022-08-10",
            "pdf_scrape_date": "2022-12-22"
        }
    }
}